Oncology patients are among the most vulnerable in the current pandemic. Will that lead to more outmigration of therapies and increased use of hypofractionation? HBI speaks to operators in the France, Germany and the UK.
Dutch insurers say they will pay for empty beds in nursing homes to prevent them falling into bankruptcy, as COVID-19 has hit the sector hard. HBI talks to an Arnhem-based consultant to find out more.
Teleradiology providers across Europe have seen volumes crash for elective reads because of the shut down of non-essential work in public hospitals, while emergency reads have been less badly affected. But operators' low fixed costs should mean that profits will hold.
Despite soaring coronavirus cases, India is lifting the lockdown it put in place at the end of March. HBI talks to one concerned operator who acknowledges that though cases are set to soar, the economic imperative is too compelling to ignore.
Dental practices in England are set to reopen on Monday, June 8, but there has been widespread concern about how guidance has been released to the sector, and some anger over the timing of the reopening which, HBI hears, may be too soon.
Covid has had a dramatic short-term impact on the lab sector with big falls in revenue halving as elective business fell away. But it is also an opportunity as new mass markets open up. And it may change the relationship between lab operators, consumers and government payors for good. It could also lead to a […]
Small and medium healthcare facilities across Sub-Sarahan Africa are facing liquidation with Africa Healthcare Federation reporting an average 40% revenue drop in March. Even the maternity sector, which has held steady in Europe, has seen fewer admissions in Kenya.
Spain's dental clinics are re-opening with infection control protocols after being largely closed for months, but the market is expected to shrink by 20% in 2020. On top of the dealing with the COVID-19 pandemic, the largest players have been busy re-shuffling their boards and striking agreements with creditors.
Regulatory body Public Health England (PHE) has ordered telehealth player Babylon to stop selling B2C antibody tests until it has established their accuracy. Supplier Abbott has already said that the test is not suitable for home sample collection but players are still scrambling to sell in what's likely to be a multi-billion market.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.